| 英文别名 |
Propanethioic acid,2-methyl-, S-[2-[[[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino]phenyl] ester;Dalcetrapib;CETP inhibitors;Dalcetrapib (JTT-705, RO4607381);Dalcetrapib(JTT-705,JTT705,RO4607381);JTT705;JTT-705;S-2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl 2-methylpropanethioate;RO 4607381;RO-4607381;Unii-3D050liq3h;S-[2-[[1-(2-ethylbutyl)cyclohexane]carbonylamino]phenyl]-2-methylpropanethioate;2-Methylpropanethioic acid S-[2-[1-(2-ethylbutyl)cyclohexylcarboxamido]phenyl] ester;JTT 705;RO4607381;3D050LIQ3H;AK185456;S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate;PubChem22426;Tube711;Dalcetrapib (USAN/I;FT-0769704;D09708;s-[2-[1-(2-ethylbutyl)cyclohexanecarbonylamino]-phenyl] 2-methylthiopropionate;Thioisobutyric acid S-(2-{[1-(2-ethyl-butyl)-cyclohexanecarbonyl]-amino}-phenyl) ester;Dalcetrapib (JTT-705);GTPL12972;AMY21305;CCG-264995;AS-55940;SW219843-1;Q5210285;DALCETRAPIB [MI];Dalcetrapib [USAN:INN];Dalcetrapib, >=97% (HPLC);s2772;BRD-K18849474-001-01-0;J-510086;BCPP000268;CHEMBL313006;BDBM50092197;JTT-705;S-2-(2-ethylbutyl)-2-formamidocyclohexyl 2-methyl-2-phenylpropanethioate;AKOS015966940;DALCETRAPIB [WHO-DD];DB12181;YZQLWPMZQVHJED-UHFFFAOYSA-N;S-[2-({[1-(2-ethylbutyl)cyclohexyl]carbonyl}amino)phenyl] 2-methylpropanethioate;DALCETRAPIB [INN];Dalcetrapib pound JTT-705 pound(c);211513-37-0;DALCETRAPIB [USAN];PB12356;DTXSID70943475;BCP9000580;RG-1658;NS00069699;PROPANETHIOIC ACID, 2-METHYL-, S-(2-(((1-(2-ETHYLBUTYL)CYCLOHEXYL)CARBONYL)AMINO)PHENYL) ESTER;AC-27462;Dalcetrapib (USAN/INN);S-(2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl) 2-methylpropanethioate;CHEBI:95001;MFCD06407886;HMS3656F06;A25148;EX-A092;C23H35NO2S;SCHEMBL528622;CS-0916;NCGC00386198-05;HY-14950;S-(2-(1-(2-ethylbutyl)cyclohexane-1-carboxamido)phenyl) 2-methylpropanethioate;BRD-K18849474-001-03-6;GLXC-03771;BRD-K18849474-001-04-4 |